Literature DB >> 31200732

Retraction Note: Decreased miR-154 expression and its clinical significance in human colorectal cancer.

Yang Kai1, Cheng Qiang2, Pan Xinxin1, Zhou Miaomiao1, Lin Kuailu3.   

Abstract

The Editor-in-Chief is retracting this article [1] due to overlap with the following articles (amongst others) [2-6].

Entities:  

Year:  2019        PMID： 31200732      PMCID： PMC6570869          DOI： 10.1186/s12957-019-1647-z

Source DB:  PubMed          Journal:  World J Surg Oncol        ISSN： 1477-7819            Impact factor:   2.754


Retraction note: World J Surg Oncol https://doi.org/10.1186/s12957-015-0607-5 The Editor-in-Chief is retracting this article [1] due to overlap with the following articles (amongst others) [2-6]. None of the authors have responded to any correspondence from the Editor-in-Chief or publisher about this retraction.
  6 in total

1.  The microRNA-217 functions as a tumor suppressor and is frequently downregulated in human osteosarcoma.

Authors:  Baoyong Sun; Mingshan Yang; Min Li; Fangxin Wang
Journal:  Biomed Pharmacother       Date:  2015-02-26       Impact factor: 6.529

2.  Decreased miR-154 expression and its clinical significance in human colorectal cancer.

Authors:  Yang Kai; Cheng Qiang; Pan Xinxin; Zhou Miaomiao; Lin Kuailu
Journal:  World J Surg Oncol       Date:  2015-06-06       Impact factor: 2.754

3.  Decreased microRNA-224 and its clinical significance in non-small cell lung cancer patients.

Authors:  Dan Zhu; Hui Chen; Xiguang Yang; Weisong Chen; Linying Wang; Jilin Xu; Long Yu
Journal:  Diagn Pathol       Date:  2014-11-19       Impact factor: 2.644

4.  miRNA-27b targets vascular endothelial growth factor C to inhibit tumor progression and angiogenesis in colorectal cancer.

Authors:  Jun Ye; Xianguo Wu; Dang Wu; Pin Wu; Chao Ni; Zhigang Zhang; Zhigang Chen; Fuming Qiu; Jinghong Xu; Jian Huang
Journal:  PLoS One       Date:  2013-04-12       Impact factor: 3.240

5.  MicroRNA-145 downregulation associates with advanced tumor progression and poor prognosis in patients suffering osteosarcoma.

Authors:  Mingjie Tang; Lijun Lin; Haikang Cai; Jie Tang; Zubin Zhou
Journal:  Onco Targets Ther       Date:  2013-07-08       Impact factor: 4.147

6.  MiR-206 functions as a tumor suppressor and directly targets K-Ras in human oral squamous cell carcinoma.

Authors:  Feiou Lin; Linjie Yao; Jin Xiao; DengFeng Liu; Zhenyu Ni
Journal:  Onco Targets Ther       Date:  2014-09-11       Impact factor: 4.147
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.